글루타티온 시장 : 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Glutathione Market was valued at USD 252.9 million in 2024 and is projected to grow at a CAGR of 6.8% between 2025 and 2034. This growth is primarily fueled by the increasing awareness of glutathione's antioxidant properties and its health-enhancing benefits. Widely used in pharmaceuticals, cosmetics, and dietary supplements, glutathione's demand is on the rise due to its ability to neutralize free radicals and support overall well-being.

In the pharmaceutical sector, glutathione plays a critical role in addressing health issues related to detoxification, oxidative stress, and aging. Its expanding application in healthcare has significantly contributed to its market growth. The cosmetic industry also leverages glutathione for its beneficial effects on skin health, driving demand for beauty and skincare products. Additionally, its inclusion in dietary supplements as an immunity booster has captured the interest of health-conscious consumers, further bolstering market demand.

The reduced glutathione (GSH) segment dominated the market in 2024, accounting for USD 162.1 million in revenue. This form of glutathione is known for its superior bioavailability and effectiveness, making it a preferred choice across various applications. As a powerful antioxidant, GSH plays an essential role in detoxification, immune system support, and combating oxidative stress. Its prominence in the healthcare, beauty, and wellness sectors underscores its growing importance, while advancements in production techniques continue to enhance its accessibility.

Pharmaceutical applications remain a key driver of the glutathione market, generating USD 114.2 million in 2024. The use of glutathione in therapeutic formulations, particularly for addressing oxidative damage and detoxification, highlights its critical role in healthcare. Ongoing research and innovation are opening new avenues for its utilization, reinforcing its status as a vital ingredient in medical treatments.

The U.S. glutathione market, valued at USD 71.2 million in 2024, is expected to grow at a CAGR of 7.1% through 2034. The robust healthcare infrastructure and increasing consumer interest in health-promoting products are fueling growth in this region. The rising use of glutathione in wellness and personal care, combined with advancements in research and biotechnology, further strengthens the market's outlook in the U.S.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Supplier landscape
• 3.3 Profit margin analysis
• 3.4 Key news & initiatives
• 3.5 Regulatory landscape
• 3.6 Impact forces
  • 3.6.1 Growth drivers
    • 3.6.1.1 Rising demand for antioxidants in health and wellness
    • 3.6.1.2 Growing adoption in skincare and anti-aging products
    • 3.6.1.3 Increasing awareness of glutathione’s detoxifying properties
  • 3.6.2 Industry pitfalls & challenges
    • 3.6.2.1 High production costs of glutathione
• 3.7 Growth potential analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Produced, 2021-2034 (USD Million) (Kilo Tons)

• 5.1 Key trends
• 5.2 Glutathione reduced
• 5.3 Glutathione oxidized

Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Million) (Kilo Tons)

• 6.1 Key trends
• 6.2 Pharmaceutical
• 6.3 Cosmetics
• 6.4 Nutraceutical
• 6.5 Food

Chapter 7 Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Kilo Tons)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 UK
  • 7.3.2 Germany
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Russia
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 South Korea
  • 7.4.5 Australia
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Anhui GSH Bio-Technology
• 8.2 Cayman Chemical Company
• 8.3 Haihang Industry
• 8.4 Herbo Nutra
• 8.5 Kaiping Genuine Biochemical Pharmaceutical
• 8.6 KOHJIN Life Sciences
• 8.7 Kyowa Hakko Bio
• 8.8 Meteoric Biopharmaceuticals
• 8.9 Shandong Jincheng Biological Pharmaceutical
• 8.10 Xi’an Fengzu Biological Technology
• 8.11 YAOPHARMA